baber/WOPTO huggingface dataset:
Patent CA-2373088-A1 (CA)
Title: Parts feed device
Inventor: GERTSCH CHRISTOPH
IPC: B65G27/32
Filed: 2000-05-03
Abstract: The invention relates to a parts feed device for a robot having a selection zone (40) accessible by the robot, a device (40) for stochastic modification of the orientation and/or position of the parts and a device with a parts recirculating element (3) for recirculating said parts. The device (40) for stochastic modification of the orientation and/or position of the parts is embodied as a vibrating platform (40) serving at the same time as selection zone (40). The parts recirculating element (30) and the vibrating platform (40) can be placed in two different positions relative to one another in such a way that the vibrating platform (40) can be supplied with parts from the parts recirculating element (30) in the first position and the parts falling down from the vibrating platform (40) can be picked up by the parts recirculating element (30) in the second position. Due to the fact that the parts recirculating element (30) is embodied both as a partial reservoir for feeding parts to the vibrating platform (40) from the parts recirculating element (30) and as pickup element (30) for the parts falling down from the vibrating platform (40), the parts feed device can be used without a parts transport device for horizontal conveyance of said parts such as conveyor belts, linear rails or the like, thereby enabling extremely simple and space-saving parts feed device construction.
Patent CA-2373987-A1 (CA)
Title: Mattress assembly
Inventor: ELLIS CRAIG D
IPC: A47C27/08
Filed: 2000-06-30
Abstract: A mattress assembly (10) for supporting a patient (98) includes a body suppo rt portion (56) having a head end (71), a foot end (75), and a knee support portion (73). The body support portion (56) has a first air zone (70) extending from the head end (71) to the knee support portion (73) and a seco nd air zone (72) extending from the knee support portion (73) to the foot end (75). The mattress assembly (10) also includes a control module (54) configured to supply air to the first and second air zones (70, 72) to maintain the first air zone (70) at a substantially constant first pressure and to maintain the second air zone (72) at a substantially constant second pressure. The second pressure is less than the first pressure to provide reduced pressure on a patient's calves and feet located on the second air zo ne (72).
Patent CA-2375787-A1 (CA)
Title: Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abc1
Inventor: WADE DAVID
IPC: G01N33/53
Filed: 2000-06-16
Abstract: The present invention relates to novel ABC1 polypeptides and nucleic acid molecules encoding the same. The invention also relates to recombinant vectors, host cells, and compositions comprising ABC1 polynucleotides, as well as to methods for producing ABC1 polypeptides. The invention also relates to antibodies that bind specifically to ABC1 polypeptides. In addition, the invention relates to methods for increasing cholesterol efflux as well as to methods for increasing ABC1 expression and activity. The present invention further relates to methods for identifying compounds that modulate the expression of ABC1 and methods for detecting the comparative level of ABC1 polypeptides and polynucleotides in a mammalian subject. The present invention also provides kits and compositions suitable for screening compounds to determine the ABC1 expression modulating activity of the compound, as well as kits and compositions suitable to determine whether a compound modulates ABC1-dependent cholesterol efflux.
Patent CA-2376064-A1 (CA)
Inventor: KLINGLER OTMAR
IPC: A61K38/00
Filed: 2000-05-27
Abstract: L'invention concerne des composés de formule (I) dans laquelle R?1¿, R?2¿, R?91¿, R?92¿, R?93¿, R?94¿, R?95¿, R?96¿, R?97¿, r, s et t sont tels que définis dans les revendications. Les composés de formule (I) sont de précieux composés actifs sur le plan pharmaceutique. Ils possèdent un puissant effet antithrombotique et sont par exemple utiles dans la thérapie et la prévention de maladies thromboemboliques et de resténoses. Les composés sont des inhibiteurs réversibles du facteur VIIa de coagulation et peuvent généralement s'utiliser dans des conditions présentant une activité indésirable du facteur VIIa ou dans le traitement ou la prévention de conditions dans lesquelles une inhibition du facteur VIIa est recherchée. L'invention concerne également des procédés de préparation des composés de formule (I), l'utilisation de ces derniers, notamment en tant que principe actif dans des médicaments, et des préparations pharmaceutiques renfermant lesdits composés.
Patent CA-2380799-A1 (CA)
Inventor: UDEM STEPHEN A
IPC: C12N1/21
Filed: 2000-08-02
Abstract: This invention relates to a method for recombinantly producing, via rescue o f mumps virus, a nonsegmented, negative-sense, single-stranded RNA virus, and immunogenic compositions formed therefrom. Additional embodiments relate to methods of producing the mumps virus as an attenuated and/or infectious viru s. The recombinant viruses are prepared from cDNA clones, and, accordingly, viruses having defined changes, including nucleotide/polynucleotide deletion s, insertions, substitutions and re-arrangements, in the place of the genome ar e obtained.
Patent CA-2381928-A1 (CA)
Inventor: FRASER LYNN REPSIS
IPC: A61K38/08
Filed: 2000-08-24
Abstract: L'invention concerne une médication combinée permettant d'accroître la capacitation du sperme chez les mammifères, qui comporte au moins deux agents sélectionnés dans les groupes consitués par 1) la calcitonine, 2) l'angiotensine II, et 3) un modulateur de l'activité du récepteur de l'adénosine, pouvant être un peptide de promotion de la fertilisation (FPP), l'adénosine ou un agoniste spécifique du récepteur de l'adénosine. Une combinaison préférée est la calcitonine, le FPP (ou FPP/adénosine), et l'angiotensine II. Les agents peuvent être formulés comme 1) crème, gelée ou pessaire renfermant de 100 nM à 100 µM de FPP ou de 10 µM à 10 mM d'adénosine, de 5 ng/ml à 5 µl/ml de calcitonine de saumon ou de 200 ng/ml à 200 µl/ml de calcitonine humaine et de 1 nM à 1 µM d'angiotensine II, ou 2) comme une préparation de sperme à utiliser dans le traitement de l'infertilité humaine, renfermant de 12,5 à 500 nM de FPP ou de 0,5 µM à 100 µM d'adénosine, de 0,5 à 150 ng/ml de calcitonine de saumon ou de 2 ng/ml à 1000 ng/ml de calcitonine humaine, et renfermant de 0,1 à 100 nM d'angiotensine II. Dans des applications agricoles, une préparation de sperme peut contenir des concentrations plus importantes de FPP, de 12,5 à 500 nM de FPP ou d'adénosine, de 0,5 à 100 µM, de calcitonine de saumon, de 0,5 à 400 ng/ml ou de calcitonine porcine, de 2 à 1000 ng/ml, et d'angiotensine II, de 0,1 à 100 nM. L'invention concerne également l'utilisation de l'angiotensine II seule dans la préparation d'un médicament destinée à stimuler la capacitation de sperme chez les mammifères.
Patent CA-2387099-A1 (CA)
Inventor: YAMAUCHI KOJI
IPC: A61F2/86
Filed: 2001-04-27
Abstract: The present invention provides an artificial dura mater which comprises an amorphous or low crystallinity polymer as a constituent component and which prevents the cerebrospinal fluid leakage.
Patent CA-2387671-A1 (CA)
Inventor: TELLO EDGAR
IPC: A44C17/02
Filed: 2002-06-04
Abstract: A jewellery piece or ring is provided with a decorative element generally upstanding from a base and which is free to rotate about an axis in full view of the wearer.
Patent CA-2387763-A1 (CA)
Title: A cable coupling device
Inventor: SILFVERBERG KIM
IPC: H01R13/52
Filed: 2000-10-19
Abstract: A cable coupling device which includes a coupling body (22) that has a through passing passageway (21) for receiving an associated end of a cable (1). The body carries a cup-shaped electric contact whose edge forms a crimping ring that tightly surrounds a body part (23) of reduced diameter. A bared conductor element (11) is placed between the electric contact and the body part (23). The crimping ring compresses the body (22) so as to seal the wall of the passageway against the cable sheath. A sealing sleeve (50) can bridge two bodies (22) which are each connected to a cable (1) and are conductively coupled via respective electric contacts. The sleeve (50) therewith provides a sealed enclosure of the mutually coupled parts of the cables in a region delimited by the sleeve and the bodies (22).
Patent CA-2390600-A1 (CA)
Inventor: HEARD JACQUELINE
IPC: C12N15/29
Filed: 2000-11-14
Abstract: Recombinant polynucleotides and methods for modifying the phenotype of a plant are provided. In particular, the phenotype that is being modified is a plant's seed characteristics.
Patent CA-2391299-A1 (CA)
Title: Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
Inventor: JOHNSON DAVID A
IPC: A61K31/7028
Filed: 2000-11-13
Abstract: Aminoalkyl glucosaminide phosphate (AGP) compounds that are adjuvants and immunoeffectors are described and claimed. The compounds have a 2-deoxy-2- amino glucose in glycosidic linkage with an aminoalkyl (aglycon) group. Compounds are phosphorylated at the 4 or 6 carbon on the glucosaminide ring and comprise three 3-alkanoyloxyalkanoyl residues. The compounds augment antibody production in immunized animals as well as stimulate cytokine production and activate macrophages. Methods for using the compounds as adjuvants and immunoeffectors are also disclosed.
Patent CA-2393293-A1 (CA)
Title: Duct burner
Inventor: BRANDON ROBERT
IPC: F02K3/10
Filed: 2002-07-15
Abstract: A recuperated microturbine system including a low temperature duct burner in the exhaust gas which accommodates significant variations in the exhaust gas flow from the recuperator, which burns the added hydrocarbon fuel, for example natural gas, reasonably efficiently, without generating a significant amount of additional NO x. A wire mesh burner is used to burn the added fuel in part of the exhaust gas from the recuperator. The duct burner is operated either in a more or less radiant combustion mode, or in a blue flame mode. The remainder of the recuperator exhaust gas, which bypasses the afterburner, is heated mainly by radiant heat transfer from the wire mesh burner. The use of the wire mesh burner minimises additional NO x formation. In the duct burner the dynamic pressure of the exhaust gas is used to overcome the inherent static pressure loss of the wire mesh burner. The fuel flow, and exhaust air flow, to the burner are both controlled to provide stable combustion, in relation to the heat content required in the exhaust gas.
Patent CA-2395495-A1 (CA)
Title: Dispositif et procede permettant le fonctionnement protege de neuroprotheses
Inventor: ORTMANN VALERIJ
IPC: A61N1/372
Filed: 2000-07-13
Abstract: La présente invention concerne un système permettant de protéger le fonctionnement de neuroprothèses, qui sont conçues pour traiter des troubles fonctionnels du système nerveux, par rapport à un accès non autorisé à des données fonctionnelles ou de fonctionnement. Ce système de protection de neuro-implant (NIS) est notamment caractérisé en ce qu'au moins un composant de neuroprothèse est implanté de façon à être en contact ou en association active avec un tissu nerveux, en ce que les neuroprothèses ne fonctionnent que pendant la période d'une autorisation spécifique, et/ou en ce que le fonctionnement comprend une transmission de données autorisée entre des composants externes et implantés et/ou une communication autorisée afin de surveiller et/ou de déterminer l'état fonctionnel des neuroprothèses et/ou la communication entre des composants externes et implantés est codée.
Patent CA-2397741-A1 (CA)
Inventor: WANG AIJUN
IPC: C07K19/00
Filed: 2001-01-16
Abstract: Compositions and methods for the therapy and diagnosis of cancer, particular ly prostate cancer, are disclosed. Illustrative compositions comprise one or mo re prostate-specific polypeptides, immunogenic portions thereof, polynucleotide s that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly prostate cancer.
Patent CA-2398944-A1 (CA)
Title: Retaining and guiding device
Inventor: FOUNTOULAKIS TZANIS
IPC: A47D13/08
Filed: 2001-01-11
Abstract: A retaining and guiding device is claimed, which can serve as a substitute for a lead, and can always be carried along without a person or animal being impeded, which is achieved by an inner band (1) directed inwards, and features an outer band (2) guided over the inner band on the outside, whereby the outer band (2) is designed as elastically elongatable or extendible against a resto-ration force.
Patent CA-2402463-A1 (CA)
Title: Transformed plant having heterologous glucan branching enzyme activity
Inventor: SORENSEN IBEN SCHILDT
IPC: C12N15/56
Filed: 2001-03-16
Abstract: The present invention relates to a transformed plant having a reduced endogenous starch branching enzyme (SBE) activity, and having a heterologous  glucan branching enzyme (GBE) activity. The invention also relates to starch  obtainable from such a plant.
Patent CA-2407354-A1 (CA)
Inventor: ANDERSEN KIM TOFT
IPC: A23C19/05
Filed: 2001-04-27
Abstract: The present invention relates to the field of cheese manufacturing. In particular, there is provided a novel method for making cheese involving the preparation of a cheese curd using a curdling agent and wherein a lactic acid bacterial starter culture is introduced into the resulting cheese curd. The advantage of the present method is that is possible to produce a large amount of cheese curd which may subsequently be divided into smaller portions each of which can be inoculated with specific and designed lactic acid bacterial starter culture to obtain different types of cheese or different ripening profile (storage time) for the same cheese type. Thus, this method is useful in the manufacturing of a variety of cheese types originating from a single curd.
Patent CA-2408673-A1 (CA)
Inventor: ZEITLER DAVID W
IPC: B65G47/31
Filed: 2001-05-11
Abstract: L'invention concerne un système d'induction de convoyeur (38) qui comprend un sous-système (52) servant à déterminer le moment auquel la commande de vitesse de déplacement d'un article passe d'un convoyeur (22, 24) à un autre. Ce système d'induction comprend également un sous-système (40) servant à créer ou réguler avec précision les espaces entre les articles sur le convoyeur. Le sous-système (38) vérifie la position et les changements de vitesse d'un article lorsqu'il passe entre deux convoyeurs fonctionnant à des vitesses différentes. Le sous-système de régulation d'espace (40) permet un contrôle et une mesure en temps réel des espaces entre les paquets. Les espaces mesurés entre les paquets sont introduits dans un système d'asservissement (72) qui modifie la vitesse d'un convoyeur afin de changer l'espacement si nécessaire.
Patent CA-2408729-A1 (CA)
Inventor: SIEKIERKA JOHN
IPC: A61F2/06
Filed: 2001-05-14
Abstract: A drug and drug delivery system may be utilized in the treatment of vascular disease. A local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography. The local delivery of the drugs or agents provides for increased effectiveness and lower systemic toxicity.
Patent CA-2409504-A1 (CA)
Inventor: STERN RICHARD M
IPC: D06M13/438
Filed: 2000-10-25
Abstract: A water- and oil-repellent composition comprises (a) a repellency-imparting, fluorochemical composition comprising at least one fluorine-containing aromatic ester oligomer comprising (1) at least two repeat units derived or derivable from the reaction of at least one dicarboxylic acid (or a derivative thereof) and at least one polyol, with the proviso that either the dicarboxylic acid (or derivative) or the polyol (or both) is aromatic or heteroaromatic, and (2) fluorochemical endgroups derived or derivable from the reaction of (i) the dicarboxylic acid (or derivative) and at least one fluorine-containing monoalcohol, or (ii) the polyol and at least one fluorine-containing monocarboxylic acid; and (b) a treatable substrate; with the proviso that, when the treatable substrate comprises a mixture of at least two polymers, the mixture is non-stratifying.
Patent CA-2409812-A1 (CA)
Title: Shock absorber with adjustable valving
Inventor: LEMIEUX RENE
IPC: F16F9/44
Filed: 2002-10-28
Abstract: A shock absorber includes a shock rod and piston which are disposed within a fluid chamber within a shock body. The piston separates the shock body fluid chamber into a compression fluid chamber and a rebound fluid chamber. A reservoir fluid chamber accommodates the entry of the shock rod into the fluid chamber as the shock absorber compresses under shock forces. The compression fluid chamber is in fluid communication with the reservoir fluid chamber through a third chamber or passage. A first valve may control passage of fluid from the compression fluid chamber into the passage. Second and third valves may be disposed within the passage in parallel with each other and in series with the first valve. The third valve may include an easily accessible knob disposed outside the shock body.
Patent CA-2410057-A1 (CA)
Title: Apparatus and method for input of ideographic korean syllables from reduced keyboard
Inventor: FUX VADIM
IPC: G06F3/01
Filed: 2002-10-29
Abstract: Systems and methods for input of text symbols into an electronic device comprising a reduced keyboard having keys representing a plurality of characters are disclosed. Possible symbol variants are identified based on character inputs received from the reduced keyboard. Each identified symbol variant is grouped into one of a plurality of groups of symbol variants, each group having an associated priority, according to a type of the symbol variant. Within at least one of the groups, the symbol variants are ranked in decreasing order of frequencies of use of the symbol variants. A list of symbol variants comprising the plurality of groups of symbol variants in order of decreasing priority is then displayed, and an input symbol is selected from the list of symbol variants. The symbol variants of the at least one of the groups of symbol variants are thereby sorted by both priority and frequency of use.
Patent CA-2410829-A1 (CA)
Inventor: BURK RICHARD
IPC: H01H9/54
Filed: 2001-05-23
Abstract: The invention relates to an electronic circuit arrangement comprising a circuit breaker (10). The circuit breaker comprises an on-off switch (1); a first interface (2); a voltage divider (3); a connection for an external voltage supply (4); a ground connection (5). The interface (2) is connected in a flexible manner in such a way that it operates as input for detecting a state and as output for power control. The circuit breaker comprises a second interface (6) which is used to connect an evaluation and/or diagnostic unit.
Patent CA-2412605-A1 (CA)
Inventor: GUAGLIANO PETER A
IPC: A61B17/02
Filed: 2001-05-07
Abstract: L'invention concerne un procédé et un dispositif représenté dans les figures 8-10, dans lequel un élément (208) fluide expansible est placé de manière concentrique autour d'une aiguille (202). L'élément (208) fluide expansible est expansé dans l'espace potentiel du nucleus pulposus bordé par l'anneau fibreux d'un disque intervertébral. Puis on injecte, au moyen d'une aiguille (202), une matière thermoplastique fluide dans l'anneau fibreux pour provoquer un affaissement de l'élément (208) fluide expansible, de sorte que la matière thermoplastique remplisse l'espace qu'occupait l'élément (208) fluide expansible.
Patent CA-2414148-A1 (CA)
Title: Targeted ligands
Inventor: HERMAN WILLIAM
IPC: A61K47/48
Filed: 2002-12-30
Abstract: The invention contemplates a composition containing a multispecific ligand containing at least a first ligand binding moiety and a second ligand binding moiety. The first ligand binding moiety specifically binds with a pre-selected first affinity to at least a first ligand. The first ligand has a first biodistribution. The second ligand binding moiety specifically binds with a pre-selected affinity to at least a second ligand. The second ligand has a second biodistribution. The affinity of first and second ligand binding moieties are selected to bias the biodistribution of the multispecific ligand in favour of a selected location of one or both of the ligands.
Patent CA-2417138-A1 (CA)
Inventor: BEAUDOIN NORMAND
IPC: F01C1/22
Filed: 2003-01-30
Abstract: La présente solution technique a pour objet d'améliorer les méthodes de soutient de machines déjà exposées par nous-mêmes, et d'en généraliser l'application, ces machines étant les machines à piston rectiligne, et les machines à piston Slinky. Par exemple, la présente invention a pour objet de montrer que l'on peut mécaniser différemment les machines motrices dites rectilignes, non rotative, par un double vilebrequin, et de plus les produire, comme dans nos travaux antérieurs à ce sujet une action purement du piston en traction. De plus, la présente invention montrera., en ce dernier cas, comment relier le piston de .telle manière de produire une machine à action rectiligne à traction sans temps mort .Ensuite, nous montrerons comment produire la machine de façon rotative. Finalement nous réitérerons que ces machines peuvent être réalisées de façons diverses, directement comme moteurs, pompes, machines de captation, mais aussi de façon indirectes, comme pédaliers, scies sautes, marteaux cogneurs.
Patent CA-2419264-A1 (CA)
Title: Repeteur sans fil a large bande pour systeme de communication mobile
Inventor: KIM HYUNG GUN
IPC: H04B7/155
Filed: 2002-09-17
Abstract: L'invention concerne un répéteur sans fil à large bande pour système de communication sans fil. Le répéteur sans fil à large bande comprend généralement un étage de transmission et un étage de réception. L'étage de transmission comprend un commutateur RF destiné à établir une trajectoire de fréquence, une unité de retard de fréquence intermédiaire destinée à appliquer un retard aux fréquences intermédiaires (IFs) et à dériver le retard IF, un modulateur d'élévation de fréquence, un amplificateur, une unité de filtrage destinée à éliminer des signaux de bande non désirés, et une antenne de transmission. L'étage de réception comprend une antenne réseau, une unité de filtrage passe-bande destinée à éliminer les signaux de bande non désirés, un amplificateur, un déphaseur destiné à régler les phases des canaux, un modulateur d'abaissement de fréquence, une unité de comparaison de phase, une unité de comparaison de gain, un dispositif d'optimisation des valeurs vectorielles destiné à réduire les erreurs des signaux principaux avec une sortie maximale, et un module de synthèse destiné à détecter et à stocker les niveaux de sortie des canaux.
Patent CA-2420389-A1 (CA)
Inventor: CHIOU YU-MIN CATHERINE
IPC: C11D3/37
Filed: 2001-08-24
Abstract: L'invention concerne une composition pour lave-vaisselle comprenant des polymères présentant une charge positive et des entités solubles dans l'eau qui réduisent la formation de dépôts de phosphates. La composition pour lave-vaisselle présente d'excellents avantages concernant le nettoyage et l'apparence du verre, même en l'absence d'additifs contenant du NaCl.